Medically Speaking: GERD

Published Online: Friday, July 20, 2012
Follow Pharmacy_Times:
In this podcast interview, Bruce Greenwald, MD, a gastroenterologist at the University of Maryland Medical Center, offers an introduction to gastroesophageal reflux disease (GERD) addressing the following topics: disease overview; symptoms; risk factors; treatment by behavioral management and medication; possible complications; endoscopy as a diagnostic procedure; and when to consult a physician about GERD.
 
To listen to the podcast, click here.
Related Articles
Gastroesophageal reflux disease and atrial fibrillation are 2 of the most significant health concerns in the United States, and researchers suspect a link between them.
A recent study suggests that co-administering the muscle relaxant, baclofen, with the proton pump inhibitor (PPI), omeprazole, may be more effective than PPI monotherapy in reducing heartburn and regurgitation in patients with gastroesophageal reflux disease (GERD).
A systematic review recently reported that antidepressants were beneficial for GERD patients – curbing esophageal sensation and reducing functional chest pain.
The FDA today approved Ivax Pharmaceuticals’ esomeprazole magnesium delayed-release capsules, the first generic version of AstraZeneca’s proton pump inhibitor Nexium, for the treatment of gastroesophageal reflux disease in patients aged >1 year.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$